Upload
arnold23456
View
227
Download
0
Embed Size (px)
Citation preview
7/31/2019 Musculoskeletal v0.3
1/33
Structure and function of skeletal muscles
Therefore, they will contract when we make a conscious decision to moveSkeletal muscles are under voluntary control
The fibres leading to muscles are myelinated for fast conduction of actionpotentials
Remember: NMDA and AMPA in the spinal cord will open their ionchannels in response to glutamate for FAST depolarisation
The motor neurones in the spinal cord use glutamatergic synpases
Needs to reach from the brain down to all the musclesThey need to be fast, because they tend to be the longest cells in the body
They need to conduct information from the brain to the muscle quickly forproper control
Schwann cells in the periphery are responsible for wrapping theirmembranes around the axon of the nerve to cover it in lipids
Keeps the axon insulated against the leakage of ions, allows for fasterconnections
Dense in ion channels, causes the influx of ions at these points tocontinue the conduction of the action potential
There are regular breaks in the myelin wraps though, these are call thenodes of Ranvier
Multiple Sclerosis (MS) is one of themIncurable
If these neurones are to become demyelinated, the control of skeletalmuscles can be lost
Again, myelin is used to increase conduction speeds within neurones
AnteriorMotor nerves leave the spinal cord from the ventral roots
This is called a motor unitHaving a greater 'nerves to muscle fiber' ratio leads to better control of the muscle
i.e. if one nerve controls every 3 muscle fibres, then you can have finecontrol, because you can turn on muscle fibres in multiples of 3, allowingfor a wide range of forces generated by the overall muscle
But if one nerve controls 200 fibres, it's more difficult to have fine controlbecause you can only activate muscle fibres in multiples of 200, so it's
hard to specifically control how much force is generated
Each nerve will activate a few muscle fibres at the same time
Skeletal muscles will use ACh (acetylcholine) as the transmitter at theneuromuscular junction (NMJ)
Neuromuscular Junction (NMJ)
This is where the nerve meets the muscle fibre
Allows the muscle to contract evenly, because the depolarisation spreadsfrom the middle out
If it were to be on the end, then one end will contract faster than the
other end, leading to poor co-ordination between muscles
Tends to be located at the middle of fibres
Action potential reaches the nerve terminal, and that opens the voltagegated calcium channel
Calcium will allow the vesicle to undergo exocytosis
The process at the NMJ is:
Cholinergic control at the NMJ
Musculoskeletal Page 1
7/31/2019 Musculoskeletal v0.3
2/33
7/31/2019 Musculoskeletal v0.3
3/33
Mostly at the organ of the parasympathetic systemSome glands under sympathetic control
We will be focusing on nAChR as they are used in the NMJ
5 subunits per receptorEach subunit contributes their helix to the ion pore in the middle
Allows for specific targeting of the receptors (but not 100%selectivity, so there is some cross-reactivity at high concentrations)Muscle uses 2 alpha-1 subunits, 1 beta-1 subunit, 1 gamma subunitand 1 eta subunit
Different types of receptors (muscle, CNS and ganglionic) uses differentmixes of subunits
There are 11 different types of subunits
Both binding sites must have ACh attached to open the channel
In muscle the two alpha subunits are important as they have the binding sitesfor ACh
Short distance to diffuse acrossThe binding of ACh is very fast
ACh esterase (AChE) will quickly break down ACh into choline and acetateIt comes off very fast
A lot of sodium can pass into the muscle in that time to causedepolarisation
Even if it stays on for 1ms it has an action
Blockers at the NMJ
There are some therapeutic uses of blocking actions at the NMJ
Reflexes aren't shut down, they will spasm if cutThis can cause major damage during surgery
One of them is to cause paralysis during surgery to prevent the patient frommoving around
The diaphragm is an important muscle in breathingIt is under voluntary controlTherefore, blocking actions at the NMJ causes paralysis of the muscle,which stops the patient from breathing
Blockers must be used with artificial ventilation and careful supervision
But there is a huge problem with blocking actions at the NMJ
ACh esterase inhibitors
Autoimmune reaction, antibodies made against the nACh receptorsin the muscle endplatePrevents their activation by ACh, which causes muscle weaknessIf we block AChE, then there will be more ACh in the cleft to triggermore nAChR to increase muscle strength
Treatment of Myasthenia Gravis
Organophosphates will covalently bond to the AChE to inactivatethemLeads to too much ACh being in the cleft
Remember: the diaphragm is under voluntary control,organophosphates will lead to paralysis so you stop breathing
The ACh receptors in the motor endplate will stop reacting to ACh,because the ion channels are kept open (see below for a phase I
block)
We don't cause too much activation. If you happen to causeWhy doesn't paralysis occur in the treatment of myasthenia gravis?
War agent/pesticides
The AChE can be inhibited for three reasons
Musculoskeletal Page 3
7/31/2019 Musculoskeletal v0.3
4/33
too much activation, then that causes the paralysisAntidote to non-depolarising block agents (see below)
Non-depolarising block
Causes paralysis by preventing ACh from having an effect at the ionchannel
BUT pain and other senses are not affected, if people aren't knocked outcompletely, then they can hear and feel themselves being cut apart
These agents are antagonists at the receptor
Very low (if any) bioavailability
All of them have a quarternary ammonium, therefore, they are prettymuch positively charged
Curare-based compounds were found to be non-depolarising blockers
Called the safety-factor of transmission which is natural protectionagainst neuromuscular blocking agents
Slow onset because 70-80% of the receptors need to be blocked beforeparalysis occurs
We can try to reverse this by using cyclodextrins (rings of sugars) totry and 'suck out' the drug of the receptor to stop their action
Slow recovery because they bind tightly to the receptor and stay there
These relaxants all have a slow onset and recovery
Eyes, then the face, then the limbs etc.But importantly, the respiratory muscles are the last to be paralysed,which also gives us some protection from death if a blocker wasadministered
Once the agent is metabolised, the order is the same but in reverse(respiratory muscles first, eyes last)
The blocker will cause paralysis to certain parts of the body first
Not selective enoughCauses hypotension
Older agents can actually block ganglionic nACh receptors
Because this is competitive antagonism of the nAChR, we can give the person aAChE to increase ACh to outcompete the blocker to restore normal function
Depolarising block
Causes initial contraction, then paralysisInitial contraction comes from the activity before the phase I block sets in
These agents are agonists at the receptor
The ion channels are kept open by the agent
The increase in voltage (depolarisation) is important, not theabsolute value
Therefore, depolarisation isn't possible, because it's alreadydepolarised (kept at 0mV)
So ACh release has no effect on the endplate (already depolarised)
Phase I
Tachyphylaxis/sensitisationThe ion channels naturally close due to a safety mechanism, causing
hyperpolarisation again (cell voltage drops back to -70mV)They won't open again in response to ACh for a while now
Phase II
There are two phases which are important to the action of these agents
Musculoskeletal Page 4
7/31/2019 Musculoskeletal v0.3
5/33
Two ACh molecules linked together
Not as quickly compared to ACh, half-life of 4-6 minutes comparedto a second at mostLiked by surgeons due this short period of actionGive a large initial bolus dose (quick paralysis) followed by IV
infusion to maintain for the duration of the surgery
Metabolised by a cholinesterase (but not AChE)
Causes both Phase I then Phase II block
Suxamethonium (Sux) is a clinically used agent
AChE just allows more agonists to be presentActually makes the paralysis WORSE!
These agents CANNOT be reversed by AchE
Musculoskeletal Page 5
7/31/2019 Musculoskeletal v0.3
6/33
ACh and SAR
ACh is quite a simple molecule (shown top)
Susceptible to hydrolysis (shown bottom)Simple ester on the left
Always ionised
Same goes for choline as wellRequires an active transporter to get it across the membrane
Quaternary nitrogen on the right
AChE inhibitors
May be reversible or irreversibleBut both are competitive. i.e. will bind at the active site instead of ACh
Edrophonium chloride is a reversible AChE inhibitor
Stable in water (Stays for awhile in the cleft)
This is because the positive charge on the carbon attached tothe serine means it's easier to remove the residues of theagent
In ACh, this positive charge is quite high, which is why it'skicked off so quickly
In the blocker, the positive charge on the carbon is reduceddue to resonance with the nitrogen atom
Stable in the enzyme (the enzyme-inhibitor complex takes a fewminutes to clear (compared to a few milliseconds with ACh)
Carbamate esters are resistant to hydrolysisThis class of inhibitors all have a carbamate ester instead of a simple ester
Medchem
Musculoskeletal Page 6
7/31/2019 Musculoskeletal v0.3
7/33
No positive quarternary nitrogen thoughContains a carbamate
Allows access to the Canal of Schlemm for optic drainage to counterglaucoma, which is where the pressure inside the eye is too great
Under muscarinic ACh controlIs also studied for its effects to improve cognition in Alzheimers disease
Physostigmine is able to work in the eye to contract the pupil
Irreversible AChE inhibitors
OrganophosphatesThese are phosphate esters
If you go back above, it is mentioned that the positive charge on thecarbon attached to serine determines how quickly it is kicked off theenzyme
The irreversible inhibitors undergo a process of aging, where it loses itsester groups while it's attached
This further reduces the positive charge on the phosphate, meaning itcan't be kicked off, so the active form of the enzyme can't be regenerated
The reason why they are so effective is due to the strength of bonding of theresidues to the serine
Non-depolarising agents
Notice it has two quaternary nitrogen groups, which are always charged
Remember: charge not needed to bind to AChE though
Also notice how ACh also has a quaternary nitrogen group, which isimportant in binding to the receptor
The distance between the two nitrogens is about 1.4nm, or about a 10-12carbon chain
The spacer between them is not as importantThis distance is very important
Tubocurarine is a non-depolarising agent
Musculoskeletal Page 7
7/31/2019 Musculoskeletal v0.3
8/33
They use a steroid as a spacer between the nitrogensWhy a steroid? The plant just makes them like that. If it works, it works.Rapid onset and medium-long acting
If either the liver or kidney are damaged, then clearance is reducedWhy? Because having at least one ester intact (coloured as red)means it's still active. Therefore, since it has an active metabolite,both metabolism and excretion are important factors in clearance
Renally eliminated, but metabolised in the liver
Pancuronium and Vecuronium are aminosteroids
Very good, doesn't rely on the patient's organ function forelimination
Plus it has a shorter half-life
Non-enzymatic Hoffman elimination
Instead, it is base catalysed (we still got some OH- in water remember?)Note: I don't know if we have to know the mechanism, but it's quitesimple
These esters may be cleaved but the more important thing is thealpha carbon next to it
There is an alpha carbon located next to the esters
And the positive charge from the nearby nitrogen helps too
The alpha carbon has a surprisingly acidic hydrogen due to the positivecharge on the carbonyl carbon
Then, this reaction occurs (called the Hoffman elimination reaction)
Atracurium is quite interesting due to its elimination
Depolarising agents
Musculoskeletal Page 8
7/31/2019 Musculoskeletal v0.3
9/33
Same as above, but these are connected by a flexible chainThe most commonly used one is suxamethonium (AKA Succinylcholine)
If a person lacks this esterase, then they are paralysed for longer(apnea)
Rapidly cleaved by a cholinesterase (but not AChE, which is why it lingersaround for longer)
Short half-life (desirable)
Notice it has two simple esters
Estrogen receptor modulators
Prevents side effects (e.g. tender breasts, abnormal bleeding etc)
Antagonist at the breast and uterus
Prevents the breakdown of boneAgonist at osteoblasts and osteoclasts
Raloxifene (pictured below) is an
Vitamin D
Important as a hormone in its final form (calcitriol or 1,25-dihydroxycholecalciferol)
The conversion of 7-Dehydrocholesterol to cholecalciferol by UV lightfalling on the skin
Dietary intake of cholecalciferol
Obtained from UV irradiated mushrooms, actually works prettygood
Dietary intake of ergrocalciferol
May be obtained from:
Converted from cholecalciferol to calcidiol (or 25-hydroxycholecalciferol) in the
liver
Converted to its final calcitriol form in the kidneys
Calbindin is used in the lumen of the GI tract to bind calcium to make iteasier to absorb into the body
Calcitriol will bind to the DNA after it binds to a intracellular receptor (it's asteroid) to cause transcription, especially for calcium binding protein (orcalbindin, seriously who names these things? Give him/her a medal for makingcalcium-related things so obviously easy!)
Since it causes increased calcium absorption, it increases the chance of calcified kidney stones from forming (ouch)
Major adverse reaction:
Musculoskeletal Page 9
7/31/2019 Musculoskeletal v0.3
10/33
Bisphosphonates
Two phosphate groupsR1 is almost always OH (clodronate is the only exception, uses Cl)R2 can be modified to change its activity
Have a very simple SAR:
Just the middle carbon is an oxygen
Normally in the bone, we have pyrophosphate, which looks very similar tobisphosphonates
But this is offset by the fact that it accumulates nicely in the bone
WARNING: this chelation means it must NOT be taken withmagnesium, iron or calcium containing products. Otherwise they'dchelate and prevent either being absorbedThis is REALLY important because the people takingbisphosphonates may be taking a calcium supplement as well.Tell them to take bisphosphonates at least 30 minutes before the
calcium supplement
This is due to the phosphate groups and the OH group will chelate tocalcium
Overall, the absorption of the bisphosphonates is low due to its polarity and thehalf-life in the plasma is short
Least potentOnly has a simple carbon sidechain for R2
First generation
There are three generations to consider:
Musculoskeletal Page 10
7/31/2019 Musculoskeletal v0.3
11/33
More potent (x100)Has a simple nitrogen-containing sidechain for R2
Second generation
Even more potent (x10,000)Has a heterocyclic ring containing sidechain for R2
Third generation
Except for clodronate (uses Cl, is first generation)Notice how all three generations have OH for R1
But both rely on the fact that osteoclasts break down bone, whichreleases the bisphosphonate for the osteoclast to absorb
Metabolised into compounds which compete with ATP to causeosteoclasts to apoptose
First generation:
Inhibits farnesyl diphosphate synthase (FPPS) in the HMG-CoAreductase pathway (AKA melvonate pathway)Causes changes in the cells' GTPases which affects normal function(e.g. prevents the ruffled border formation with the bone) and cellsurvival and generation (make less cells, they survive shorterperiods of time)
Second generation:
Debate about its effectiveness in osteoporosisNot thought to be effective because it just doesn't build up in bonelike bisphosphonates
There's another class of drugs which inhibits the HMG-CoA reductase
pathway, and that's the statins
Their mechanisms of actions slightly differ
Musculoskeletal Page 11
7/31/2019 Musculoskeletal v0.3
12/33
Note
The first part is very similar to the lecture given in OncologyThe notes for this lecture assumes you understand everything from that lectureThis lecture may reinforce prior knowledge or add extra details
The lecture has also missed out on a LOT of NSAID related side effects.These have been filled in
We will focus mainly on the drugs and COX pathways
Revision of the terms (some are from previous years)
From the nerve to the spineFrom the spine to the thalamus of the brain
From the thalamus to the sensory cortex
Usually consists of several neuronesPain pathways
Somatic pain- Easy to describe and locate as it's mapped to a certainpart of the brainVisceral pain- Hard to describe and locate as it's not as accuratelymapped in the brain. Usually deep tissue injuries or organs
Caused by the activation of receptors in response to a stimulusNociceptive pain
Caused by the spontaneous activation of nerves without a response to astimulus. Tends to be caused by damage to nerves (compression,inflammation, ischemic damage and metabolic injury)
Neuropathic pain
Occurs from a specific identifiable incident (i.e. you knew it happened),which goes away within days to weeks. Caused due to nociceptive pain
Acute pain
Not easy to figure out where the pain is coming from. May keep goingindefinitely. Can be nociceptive or neuropathic
Chronic pain
Small, myelinated fibres for fast conduction. Used for physical andthermal pain to cause sharp pain
A-delta-fibres
Unmyelinated fibres for slow, chronic conduction. Causes burning painC-fibres
Important safety reflexes carried out at the spinal level before centralinvolvement
This is because speed is key, we don't have time to think and give ordersto avoid further injury (e.g. touching a flame, and wincing backwards)
Sensory information feeds into the spine (as usual)But interneurones in the spine will feed back information into motornerves and trigger them to trigger the reflex
Spinal/local reflexes
Increased pain due to a painful stimulus. Could be due to sensitisation atthe nerve endings and increased central sensitisation
Hyperalgesia
Non-painful stimuli are felt as pain. e.g. pressure being felt on the skincould be interpreted as pain if the area is sunburnt
Allodynia
Inflammation and pain
Pain (again) and inflammation
Musculoskeletal Page 12
7/31/2019 Musculoskeletal v0.3
13/33
Calor- Heat produced at the site of action due to vasodilation andincreased blood flow. Increased cellular metabolism also increases thelocal heat
Rubor- Redness at the site due to vasodilation and increased blood flowTumor- Swelling due to vasodilation and leakier capillaries.Dolor- Pain, which is caused by the release of mediators and pressure on
the nerve ending due to swelling
Loss of function
First off, inflammation causes 5 things at the site of injury:
Acute- vasodilation and leakier capillaries to allow immune cells to moveinto the region
Subacute- Infiltration of cells into the regionChronic- Repair or fibrosis occurs in the region
There are three phases of inflammation as well
As you may or may not know, NSAIDs are highly recommended forinflammatory pain, and this is due to COX inhibition
Common to most cells in the bodyTherefore, most cells will be producing COX-1 products at a basallevel
So if a drug blocks COX-1, then you can expect to see gastricside effects
One of these things is PGI2 which is used to reduce gastric acidsecretion
Important for vasodilation in the kidneys to maintain themIf PGE2 is reduced, then renal damage can precipitateTherefore, if anyone has renal insufficiencies (or are diabetic
because they have fragile kidneys), they need to avoid COXinhibitors
Remember: PGE2 is also important for gastric protection
Another prostaglandin being produced is PGE2
Causes vasoconstriction and platelet aggregationNormally kept balanced by PGI2 (which reduced aggregation)PGI2 production is reduced if COX-2 is blocked, which leads toincreased clotting
Lastly, the difference between COX-1 and 2 is the production of thromboxane A2
COX-1
Induced during inflammation, which makes it a drug target
Proinflammatory prostaglandins such as PGE2 will not only causesensitisation at the nerve ending, it can also trigger pain by itself
Another role of PGI2 is to prevent platelet aggregationBlocking COX-2 will reduce PGI2, which increases the chancesof platelet aggregation and clot formation
However, it also is responsible for producing PGI2 as well
COX-2
Is like COX-1But found in the brain to produce prostaglandins thereProbably where paracetamol works (diclofenac and ibuprofenwould be too polar to get here)
COX-3
But there arethree COX isoforms in the body
The gene which codes for COX-2 has a region for glucocorticoids to bindto
If glucocorticoids bind here, it prevents the transcription of COX-2 toreduce inflammation
Glucocorticoids play a role here
Musculoskeletal Page 13
7/31/2019 Musculoskeletal v0.3
14/33
COX-1 doesn't have a region for glucocorticoids, so they don't affectCOX-1
IL-1 is a very important cytokine which is also used to increase bodytemperature (i.e. has pyrogenic effects)
The thermoregulatory centre is there
IL-1 causes activation of cells to produce PGE2 in the hypothalamus of thebrain to increase body temperature
Umm I thought he said NSAIDs won't get into the brain oh well.NSAIDs (and paracetamol) will block the production of PGE2
NSAIDs have an antipyretic effect
Side effects of NSAIDS
COX-1 activity is present in the body, and it is important for normal tissuehomeostatic
Therefore if we block it, then we're bound to cause some effects
COX-1 is responsible for the production of PGI2 and PGE2, both will act toreduce gastric acid secretion to prevent gastric/duodenal damage
Gastric effects
COX-1 is responsible for the production PGE2, which is important for renalvasodilation and renal health
Renal effects
See above for thromboxane A2 is produced by COX-1 and it's responsiblefor increased platelet aggregation, while PGI2 produced by both COX-1and COX-2 inhibits aggregation. Selective inhibition of COX-2 cause
Cardiovascular events
COX inhibition leads to increased levels of leucotrienes, which areimplicated in bronchospasm and bronchoconstriction
Therefore, for asthmatics, they should be recommended paracetamol,
and if they are given NSAIDs, they should be told to look out forsymptoms and discontinue NSAIDs if they occur
NSAID induced asthma
Can lead to swelling of the body and rashesSystemic shock can be fatal
Hypersensitivity reactions
Drugs
Very important for its anti-coagulatory activity at low doses, as
platelets cannot regenerate COX-1, so they can't producethromboxane A2 (which prevents platelet aggregation
Irreversible binding to COX-1
Unknown actionAlso has analgesic action at high doses
Damage caused by COX- 1 inhibition is bad enoughBut further damage is caused by direct irritation of the lining if aspirin is allowed to come into contact with the stomach lining
GI effects are severe
Aspirin
Non-selective COX inhibitorHas the lowest amount of side effects, so it's our first line NSAID
Ibuprofen
But it's activity is 1:5 selection for COX-2Non-selective COX inhibitor
Higher risk for GI symptoms
Diclofenac
Paracetamol
Musculoskeletal Page 14
7/31/2019 Musculoskeletal v0.3
15/33
Due to chemical definition, it doesn't have an easily ionisable acidNot an NSAID
Good for analgesia and antipyretic effects
Be wary of a overdose of paracetamol, causes severe liver damageConsidered to be very well tolerated
Musculoskeletal Page 15
7/31/2019 Musculoskeletal v0.3
16/33
Quick intro
DMARD stands for Disease modifying anti-rheumatic drugs
NSAIDsGlucocorticoidsAnalgesicsBecause rheumatoid arthritis is a chronic inflammatory disease
They are given as a part of a combined treatment with:
Typically has immunosuppressant functions to reduce damageAre not analgesics or anti-inflammatory (which is why we have the otherdrugs as well)
The role of DMARDs is to prevent damage to the joint
Weeks to monthsNeed to have symptomatic relief while they get to work
They take a long time to have their actions
Methotrexate
Seems to be a very popular DMARD
3-4 weeks instead of several monthsFast onset of action
Shown to be safe in pregnancyIt's cheap and it's been around for awhile now
Monitor LFTsHepatotoxicity
Monitor blood countsMyelotoxicity/myelosuppression
Skin reactions
Has adverse effects
Remember: lymphocytes rely on de novo synthesis of purines,which is why this pathway is so important to them
Inhibits dihydrofolate reductase (DHFR), which inhibits the conversion of dihydrofolate (DHF) to the useful tetrahydrofolate (THF) which is used forpyrimidine and purine depletion
Also causes indirect inhibition of thymidylate synthase indirectly byincreasing DHF levels
This leads to reduction of proliferation of T cells
Mechanism of action is well known
Dosed orally once a weekI think it affects purine synthesis more at these lower doses, since thedepletion of thymine (a pyrimidine) causes apoptosis...
Doses are lower compared to the doses used in chemo
Also causes extracellular adenosine release, which somehow reducesinflammation. The mechanism is unknown
Teratogenic, use another DMARD
Leflunomide
Prodrug which targets pyrimidine synthesisThis also means lymphocytes are restricted from dividing due to a lack of nucleotides (similar situation compared to methotrexate)
Similar efficacy to methotrexate
DMARDs
Musculoskeletal Page 16
7/31/2019 Musculoskeletal v0.3
17/33
Hepatotoxicity and myelosuppressionThis is also teratogenic, consider using another type of DMARD like thequinines or sulfasalazine
But it can also cause:Hypertension
Has similar adverse effects as well:
Gold salts
Considered to be a late stage drug, consider other drugs before gold saltsLong time to action, needs 3-4 months for action
DermatitisFlu-like symptomsDiarrhoeaHypersensitivity reactionsNephritis (and kidney damage)
Common (33% of patients see them) and severe side effects:
But it causes immunosuppressionMechanism of action is unknown (yay!)
Sulfasalazine
We have met this drug during inflammatory bowel conditions
5-aminosalicylic acid (5-ASA)Sulfapyridine
But if it reaches the large intestine (either due to enterohepaticrecirculation or just as it moves through the GI tract) the bacteria therewill cleave it into:
Absorbed in the small intestine as whole sulfasalazine
5-ASA is a anti-inflammatory compoundThe uncleaved sulfasalazine is a folate antagonist, which would reduce theproduction of cells
And it reduces the production of IgA and rheumatoid factor IgM (both areauto-immune antibodies by the way)
Mechanism of action is unclear:
Antimalarials (quinines)
Hydroxychloroqine and chloroquine are examplesNot very effective (only 50% response from patients)Can cause remission, but the damage against bone can continue while taking
this drug
Luckily it's not very toxic though
Reduces lymphocyte proliferationInhibits IL-1 release (but it's thought to be not important)Inhibits phospholipase A2, which is responsible for being along thepathway of producing inflammatory mediators
Mechanism of action isn't clear either
Penicillamine
Avoid taking any iron, magnesium or calcium containing productsHas a few sites for chelation of metal ions
IgM rheumatoid factor decreases both in the blood and synovial fluidNot anti-inflammatory
Again, mechanism of action isn't clear
Has toxic effects (limiting factor in treatment)
Musculoskeletal Page 17
7/31/2019 Musculoskeletal v0.3
18/33
Can be reversed with histamine administrationPruritus (itchy mouth), rash and stomatitis
Thought to be immune-mediated due to autoimmune reactions
Drug fever (probably immune mediated), loss of taste, nausea andanorexia can occur early in therapy
Membranous nephritis (kidney damage), myasthenia gravis,polymyositis (chronic inflammation of the muscles)MONITOR closely for symptomsStart low, go slow (i.e. start on a low dose, and titrate up slowlywhile observing side effects)
It can also precipitate autoimmune reactions in the body
Azathioprine
Met this drug a lot nowMetabolised into 6-mercaptopurineApparently it's metabolised into thiopurine metabolites and incorporated intothe DNA to stop DNA elongation
This is in addition to inhibition of IMPDH to prevent purine synthesis (see
oncology)
Onset of action is slow (several months)
Cyclosporin
I'm pretty sure we've met this one as well (yay!)See oncology module, lectures on immunosuppression and transplantsIt inhibits calcinurin to prevent calcimodulin from binding, which preventsIL-2 production
Remember: IL-2 production is required for clonal expansion of T cells
Anti IL-2 drug with a known mechanism of action
Effective when given in combination with other DMARDs
Nephrotoxicity and hypertensionHas some long-term adverse effects though:
Tumour Necrosis Factor alpha (TNF-alpha)
Stimulates neutrophils and macrophages so they move in and startcausing inflammatory damage
Plus stimulates T and B cells to grow due to macrophages beingstimulated to make IL-1
Very important role in inflammation
Inhibit the production or releasePrevent it from reaching the receptorStop the receptor from having its effects
We can either:
Administering monoclonal antibodies (e.g. infliximab) which is specificagainst TNF-alpha
Administering soluble receptors which will also bind to it as well (e.g.etanercept)
We can bind up the TNF-alpha by either:
Both are incredibly expensive
Besides, these things have a very long circulating half-life, only a fewinfusions are needed yearly
Both must be given IV or SC, as these are large proteins, they will not be orally
bioavailable as they are too large
Hypersensitivity reactions/infusion reactions
Adverse effects include:
Musculoskeletal Page 18
7/31/2019 Musculoskeletal v0.3
19/33
TNF-alpha is again, very important in mounting an immuneresponse, if we prevent it from having it's action, then they becomepartially immunocompromisedPlus since we have to pierce the skin for this, that also givesincreased chances of infection
Increases chances of infections
Anakinra
The body has an endogenous IL-1 antagonist, anakinra is a recombinant form of it
Competitive inhibitor at the IL-1 receptorIL-1 receptor antagonist
Short half-life, must be administered daily SC (large protein as well)
Abatacept
Binds to CD80 and CD86
Prevents signal transduction between the antigen presenting cell and the T cellto prevent activation
Due to the lack of proper activation, it reduces cytokine synthesis andinflammation
Rituximab
Used for CD20+ non-Hodgkin's lymphomaWe saw this one from oncology (part of rCHOP)
Reduced antibody production (IgM and other autoimmune
antibodies)Interrupts the interwoven mesh that is the cytokine networks
Prevents activation of T cells and macrophages
Reduces further attacks by preventing B-cell mediated antigenpresentation (remember: their IgM can present)
Causes death and depletion of B cellsB cells can express CD20, and rituximab is an antibody which binds to it
Tocilizumab
Pro-inflammatory cytokineMonoclonal antibody against IL-6 receptors
Last-line type drug which is used if the other DMARDs and TNF-alpha blockers
don't work
Could also be given if a person can't take methotrexate (remember, it causeshepatotoxicity and skin reactions)
Musculoskeletal Page 19
7/31/2019 Musculoskeletal v0.3
20/33
Joint anatomy (lab)
Types of joints
Least mobileUses dense fibrous connective tissue to connect between bones toprevent movement
No movement mean there's no joint cavitySutures between the immature skull are an example
Fibrous joints
Fibrous cartilageTissue between the bones is held by semi-flexible cartilage
Allows some movement, and that's because the cartilage can be bentExamples are the joints between the vertebrae
Cartilaginous joints
Most mobile, but least stableDesigned for smooth, frictionless movementHas smooth articular cartilageJoint space (or potential space) exists to allow free movementLubricated by synovial fluid produced from the synovial membranes
Synovial joints
Articular cartilage
The membrane is very delicate, it would not survive long if it were to bepresent on the surfaces where they rub onto each other
Not covered by synovial membranes
Collagen arranged into a matrixComposed of 'special' type 2 cartilage
Prevents drying out and crumbling away under pressure and shocksWater also helps cartilage cushion joints against pressure and shocks aswell
Proteoglycans (aggrecans) embedded into the collagen are important, as theywill absorb and keep water within the cartilage
Subchondral bone is smooth, and it also provides an attachmentsite for the cartilage
Must be supplied by diffusion from the synovial fluid or the blood vesselrich sub-chondral bone which sits beneath the cartilage
Due to no vascularisation, it heals very, very slowly
Has no vascular supply
This is a good thing, otherwise we'd feel it each time our joints movedBut if the cartilage was to wear away, then the bones would rub ontoeach other. The bones have nerve endings, so it hurts (osteoarthritis)
Has no innervation
Will synthesise collagen and aggrecans to maintain the cartilagePressure on the joint is required to physically squeeze nutrients towardsthem, and to put pressure on them to secrete their contents
Which is why osteoarthritis can occur at older agesTheir function decreases over time, which leads to lower quality cartilage
Chondrocytes will sit in the cartilage
Bone
Pathology of arthritis and anatomy of the joints
Musculoskeletal Page 20
7/31/2019 Musculoskeletal v0.3
21/33
Organic (33%)- collagen is required to give it tensile strength (i.e. stops itfrom being too brittle)
Inorganic (66%)- inorganic ions (hydroxyapatite and calcium phosphate)for hardness and compression resistance
Strong connective tissue with organic and inorganic components
Compact (cortical) bone- dense bone which is good for resisting
compression and especially for tensile strength
Cancellous (spongy) bone- bone with struts called trabeculae, which willalign in the direction of stress. This is brought about by bone remodelling
Two types:
Synovium
One reason why it hurts like hell in an injuryGood nerve and blood supply
i.e. the membrane allows some substances to enter into the joint assynovial fluid
Blood supply is required to produce synovial fluid, as it's a filtrate of plasma
Therefore it's responsible for lubrication of the joint
Hip
Between the illium of the hip bones and the head of the femurBall and socket joint
Adduction, abduction,Flexion and extensionCircumductionRotation
Can produce many movements
i.e. since the amount of force it needs to bear is constant,increasing the area reduces the force a single area needs to bear
The larger surface area is also good to distribute all the weight to reducethe forces on the cartilage
Very stable joint as the head goes deep into the joint
Knee
Flexion, extension
Not really designed for rotation due to the shape of the condylesToo much rotation will cause massive damage to the ligaments andcapsule and even the meniscii if the forces are great
Rotation is partially possible during flexion
Synovial joint with great mobility
Meniscus deepens the joint for increased stability
They prevent adduction and abductionTwo sets of ligaments (cruciate and collaterals) will keep it held in place
Inherently unstable as the condyles don't fit into each other
Dislocation in younger people due to increased activityFracture of the femur, especially at the head (but that's at the hip)
The most common injuries are:
For lubrication and keeping the bones in the joints respectivelySurrounded by synovial membrane and a capsule
Note: image from Gray's Anatomy, 20th edition. This image is in the publicdomain, can be used without restrictions
Musculoskeletal Page 21
7/31/2019 Musculoskeletal v0.3
22/33
Spinal column
Overall movement of the spine is derived from the sum of the smallermovements between the vertebrae
Flexion, extension and lateral flexionRotation is possible as well
The spinal column is made of several vertebrae connected by cartilage disks
7 cervical vertebrae12 thoracic vertebrae5 lumbar vertebrae
Need to remember their distribution:
Diaphragm
Laticimus dorsiErectus spini
Back muscles
There are some muscles which attach to the spinal column
Image is produced by the US government. Therefore it is in the public domain
Musculoskeletal Page 22
7/31/2019 Musculoskeletal v0.3
23/33
This (above) is a cervical vertebra, the joints between the vertebrae above andbelow are less sloped to allow rotation to allow the head to rotate
Image from Gray's anatomy 20th edition
This (above) is typical for a thoracic vertebra
Ribs are attached here. Too much movement means the ribs will movearound and possibly damage the organs contained within
The lateral processes lock into each other, and the joints between the vertebraeare much more sloped to restrict movement
Arthritis (guest 'lecture')
Osteoarthritis (OA)
Wear and tear of the joint usually caused by repeated use
Increased pressure on the jointsObesity
This collagen makes up most of the articular cartilageType 2 collagen deficiency or mutation
Physical activity is important for cartilage healthReduced physical activity
Specific types of joints are affected, like the knee and jointsbetween the fingersCan be asymmetrical as one side tends to be used more
Repeated use of the joint
Other risk factors to consider are:
Due to spur formationAlong with hard, bony growths on the joints
The person can present with sharp bone pain
There is little space and bone contact which suggests the bones aredirectly touching one another instead of being separated by cartilage
The bones may appear more dense at the points of contact as a responseto wearing down
If an X-ray were to be taken, then there would be little space between thebones and the point of contact between the bones may appear more dense
Because the pain and stiffness will increase with joint use, it occurs mainlyat night
Stiffness mainly occurs in the evening, with minor stiffness in the morning
Musculoskeletal Page 23
7/31/2019 Musculoskeletal v0.3
24/33
Just analgesics I guessNo real treatments except for replacement
Rheumatoid arthritis (RA)
Inflammatory condition of the jointAuto-immune attack against the tissues of the joint, especially the lining(synovial membrane or synovium)
Female genderHLA-DR4 (MHC), so it's geneticSmoking is a major factorInfections as some infections can trigger autoimmune reactionsGeneral autoimmunity, as they tend to occur together
Risk factors are:
X-rays will show bone destruction near the corners of where the cartilageshould be, because the synovium is attached to the bone there
Converts the membrane into a pannus, which is a piece of destructiveinflammatory tissue which will attack other tissues and eat away at them
Unlike OA, the joint will be tender due to inflammation
Tends to occur in joints which aren't frequently used, like the joints of thewrist
Since it's autoimmune, it tends to be symmetrical, occurring on both sidesof the body
Also unlike OA, the joints affected are different
Early treatment is very important to prevent progression of destruction of the joints due to pannus formation
Granulomas with T cells and macrophages may be seen around the body
People can literally be frozen in place if damage is uncheckedPrevention of further damage to the bone and joint
Maintaining remission of inflammation to prevent damage
Treatment focuses on:
Patients with RA will likely be affected by another autoimmune diseasePatient with RA can have inflamed blood vessels due to general increasesin inflammation. This is associated with increased atherosclerosis andcardiovascular disease
We also have complications to think about
Increased ESR (erythrocyte sedimentation rate)Increased CRP (C reactive protein)
Inflammatory markers in the blood
Not very good for diagnosis though
Rheumatoid factor- autoantibody
Much better for diagnosis and for early detectionAnti-CCP- antibodies against citurilated proteins
Some of the diagnostic tests are:
NSAID + 1DMARD thenNSAID + 2 DMARDs thenNSAID + DMARD + biologicalSee workshop for details
The basic treatment is:
Spondyloarthritis
Ankylosing spondylitis is the most common causeInflammation of the ligaments holding the vertebrae togetherWill cause fusion of bones between the vertebra resulting in a
Defined as inflammatory disease of the joints in the spine
Musculoskeletal Page 24
7/31/2019 Musculoskeletal v0.3
25/33
permanently disfigured spineAssociated with HLA-B27
Infection by an organism leads to an autoimmune reaction due to cross-reactivity
Could be due to klebsiella
May be a reactive arthritis
Males in their early teens
Because this is an inflammatory disease as wellFocus on NSAID and anti-TNF-alpha but methotrexate won't work
Treatment is similar to that of RA, but they don't work 100%
T lymphocyte mediated insteadThere's no identified antibody which is responsible for it (yet)
Septic arthritis
Need to treat fast to prevent joint damageThis is inflammation of the joint due to bacterial infection
Staphylococci or streptococci due to their presence on the skin
Could be another manifestation of gonorrhoea
Most common pathogens are:
The joint will become red, hot and swollen
Could separate it from RA on the basis of it affecting just one joint or oneside of the body (compared to many joints on both sides of the body inRA)
But that's not diagnostic, need to take a sample (see below)
Would expect to see markers of inflammation in the blood as well
Will see pus filled liquidGram staining and culturing will give a definite answer
Best diagnostic method is to take a sample of the synovial fluid
Gout
See workshop (seriously, save yourself the waste of time this lecture has been, lucky Iwasn't here half the time)
Systemic lupus erythematosus (SLE)
Interesting because it targets the DNA and proteins of the nucleus (whichtend to wrap DNA)
Autoimmune disease
Around 35 yearsStrong bias for women again
Causes the characteristic butterfly rash on the face, which is due to aphotosensitive reaction
It appears they have RA but...There's no rheumatoid factor, no anti-CCP and not as much destruction
Affects many different tissues of the body, including the joints
Will set up inflammation in the kidneys which can lead to renalinflammation and damage
If this occurs, need to consider chemotherapy drugs likecyclophosphamide and mycophenylate mofetil to stop the immunesystem in its tracks
One large concern is the immune complexes are able to become stuck in thekidneys
Except for that, there is very little that can be done about SLE
Musculoskeletal Page 25
7/31/2019 Musculoskeletal v0.3
26/33
Intro
Diclofenac is a weak acid with an approximate pKa of 4.0
PotassiumSodiumDimethylammonium
It comes in three salts:
Which then determines the solubilityBecause it's a weak acid, its ionisation state is affected by pH
Low solubility (3.5mg/ml)At a pH of 1, it's almost completely unionised
At a pH of 6.3, it goes up to 14.7mg/mlAt a pH of 7.5, it goes up further to 26.1 mg/ml
Types of salts, formulation and absorption
Solutions as dispersible tablets or sachetsOr as a immediate release tablets without enteric coating
So you'd expect to see something like subject 1 below
All of these formulations should in theory lead to a faster release and alarger Cmax
But some diclofenac is able to be absorbed before precipitation,which leads to an initial peak which then falls down
But once these formulations reaches the stomach, the pH causes thediclofenac to precipitate out due to the decreased solubility
This leads to another peakTherefore some people will have multiple peaks (subject 2 below)
They form crystals which cannot dissolve until they reach the less acidicsmall intestine
Potassium salts are used in immediate release products
Since release is quite slow, some accumulation can occur in thebody (won't be observed with immediate release)
Uses a matrix for slow diffusion of diclofenac out from the tablet
They must be swallowed wholeThey must be resistant against dose dumping to prevent overdose
Both situations will lead to a high release in a small area, whichcould be quite erosive
They are susceptible to mucoadhesion or bezoar (glued together tablets)formation if taken together
Could glue up together and cause local erosion?Capsules with coated pellets are only available overseas
Dilute well with IV saline and infuse slowly if given IV toprevent local erosion to the vessels
IM injections, suppositories, occular solutions and IV diclofenacThe sodium salt is also used for all the other formulations
The sodium salts are used in the slow release formulations
Not completely solubilised, microparticles
These particles will remain small even after passing through the stomachTherefore will be well absorbed in the small intestine, leading to a largeCmax and hopefully no multiple peaks
The free acid is used for dispersible tablets
Pharmacokinetics
Musculoskeletal Page 26
7/31/2019 Musculoskeletal v0.3
27/33
In-vitro and in-vivo testing of products
Initially, the tablets are exposed to a medium of pH=1 to emulate what
happens in the stomach
Then they are exposed to pH 7.4 medium to simulate what happens inthe intestine
In-vitro tests (for extended release) are:
Just chuck it into 7.4 buffer and watchFor immediate release, it's a lot more simpler
Test for bioequavelenceCarry out a fasting test and a fed test to observe if a food effect is present
Need frequent times to properly detect multiple peaks if they occurAnd if they aren't sufficient, it's very hard to properly determine
Cmax and tmax (don't know what is the proper maximum) andsince the curve can't be properly defined, the AUC would be acomplete guess
Sampling times must be frequent
In-vivo tests involve a cross-over study
Animals can be handled a lot more roughly, so we can directly measurelevels in the tissues (by killing the animal and grinding up the tissues)
For humans, we measure the plasma concentration to see how much getsacross instead
In-vivo tests for transdermal delivery between humans and animals are slightlydifferent
Transdermal absorption of diclofenac
The stratum corneum layer of the skin is a lipophilic layer, which isfollowed by normal cells which presents a hydrophilic layer. This makes it
Diclofenac as its diethylammonium salt is surprisingly good at diffusing acrossthe skin
Musculoskeletal Page 27
7/31/2019 Musculoskeletal v0.3
28/33
quite impermeable against drugsWhen diclofenac is produced as the diethylammonium salt, once it entersthe liphophilic layer, they will remain associated to each other due toelectrostatic attraction (positives attract negative), which makes itsurprisingly lipophilic to allow it to pass through
But once it reaches the hydrophilic layer, both the salt and diclofenac willbecome surrounded by water molecules and dissociate, leaving theionised diclofenac, which is soluble in water and can easily move around
the body now
But it's not over yet, it still needs to reach the site of action, which is the joint, so it needs to partition across many different membranes
or it's actually theorised that it gets absorbed into the systemiccirculation, and it's then taken to the joint instead
Gels/emulsionsTreated plastersMay be covered in an occlusive dressing to keep moisture in
Some types of formulations are:
Moisture is important, as the extra water is important in increasingthe spaces between the keratinocytes which are part of thestratum corneumIf the spaces between the keratinocytes are increased, theparacellular route for diffusion across the skin is improved
Moisture and occlusive dressings
Alcohols, such as isopropyl alcohol will improve penetration,probably due to it's co-solvent properties (i.e. helps othersubstances be more soluble because they are soluble in bothphases)Polypropylene glycol is another co-solvent which can be used in
patches
Permeability enhancers
More blood flow the betterArea of the body
What are some factors which affect absorption?
Although the half-life of diclofenac is short (1-2 hours), it's delivered for along time due to either slow release product or a patch. While the tabletor patch is active, it's still releasing drug
Once we move onto the next dose, the tablet or patch may still havebeen giving off drug, which means there's still some drug left in theperson's system. Giving them a fresh patch or tablet means more drug
enters, which increases the plasma level, leading to accumulation
Flip-flop mechanics!
That means the half-life of the drug is now under absorption control, howquickly the drug goes into the person
Because the drug is delivered slowly across the skin, it's not surprising to seeaccumulation can take place
Especially when compared to an IM injection
Overall though, the amount getting absorbed into the systemic circulation isquite low
Toxicity
We tend to use enteric coatings for NSAID products due to their GI irritant
effects
But the problem is, these substances are quite irritant to cells, which is why wehave to dilute to give as an IV formulation
But all that did is move the problem downstream, wherever the entericSo we thought we could solve GI problems by putting on an enteric coat
Musculoskeletal Page 28
7/31/2019 Musculoskeletal v0.3
29/33
coat dissolves to release the NSAIDThis is especially bad, because it's harder to diagnose and treat if the irritationand ulceration occurs that deep in the GI system
Chirality
Remember it as S in NSAID, there's no R so it's easy to remember
R does have some effect (not much though)
As a rule of thumb, the S enantiomers for NSAIDs have the activity
Therefore, a chiral assay is much more important now, as we don't knowhow much of the active enantiomer is present
Unfortunately, due to pharmacokinetic differences, the S enantiomer is lessabsorbed compared to the R enantiomer
Therefore, the rate of absorption becomes another importantfactor as it can change the amount of the active substance
The R to S conversion probably occurs presystemically, so the longer itstays out in the GI tract (i.e. longer tmax), the more S enantiomer ispresent
But in the case of ibuprofen, it undergoes a one way conversion of the Renantiomer to the S enantiomer (that's a good thing, means they get moreactive in their system)
The racemate as a lower solubility compared to the pure enantiomerSo if they sold the pure enantiomer, then the solubility improves, so thedissolution rate improves, so the NSAID is absorbed faster (faster tmax)
In some countries, the S enantiomer is sold on its own, this haspharmacokinetic consequences
Chronobiology
Therefore anything with the prefix chrono- is related to timeFun fact: Chronos is the god of time
Remember: humans operate on circadian rhythms, which are dailyrhythms which affects our physiology
Chronobiology explains why there are pharmacokinetic differences due toNSAIDS being taken at different times in the day
Ironically, despite the fact that it has a higher absorption in the morning,it doesn't help
NSAIDs need to be taken a few hours before the pain to have the best
effect
But high plasma concentrations will cause greater GI symptoms insteadTherefore, having a higher AUC and Cp in the morning won't help withthe morning pain, but rather increase the GI symptoms
Conversely, it has better pain relief at night with less GI symptomsbecause the high dose taken during the morning gives great pain relief,while the AUC and Cp are low at night
If you see the diagram below, the AUC at 7am (0700h) in the morning for oralindomethacin is considerably higher compared to doses taken at night (11pm,2300h)
Musculoskeletal Page 29
7/31/2019 Musculoskeletal v0.3
30/33
Absorption
Absorption is mainly in the small intestine for the oral route with someabsorption happening in the stomach
Absorption across the skin results in a lowered bioavailability, but it'sdelivered over a long period of time
As seen above, there are many formulations of NSAIDs available, which allowsus to utilise different routes
Acid suppression is something to consider (e.g. H2 antagonists, PPIs etc)because the pH affects the ionisation (and therefore the solubility) of diclofenac (and other NSAIDs as they have similar pKa except for the
oxicams, which have a higher pKa)
But the overall amount absorbed is the same, so there's no changein AUC
If stomach pH was to be increased, then the % ionised and the solubilityincreases, so the Cmax increases as well
During absorption, we need to be careful of interactions with other drugs
Increased transit time can be seen from inflammatory bowel diseases(such as ulcerative colitis or Crohn's disease)
Which will lead to an increase in the S enantiomer : R ratioThis will lead to an increase in tmax
Another thing to consider for absorption is disease states, as they can affect thetransit time and absorption (important parameters)
Distribution
Therefore, they are mostly ionised in the bloodSo they will tend to stay in the blood, leading to a reduced Vd close toplasma
NSAIDs by definition are weak acids
0.12L/kg for diclofenac, which translates to 8.4L in a 70kg man. That'squite close to plasma (about 5L)
In addition, they are tightly bound to albumin (90%) which also helps to explainwhy the Vd is so low
Can lead to non-linear drug responses (see below)Reduced fraction at higher concentrations
Plus some drugs are able to compete for the albumin as wellAnd in some disease states, such as rheumatoid arthritis, the ongoing
The binding is concentration dependant
Musculoskeletal Page 30
7/31/2019 Musculoskeletal v0.3
31/33
7/31/2019 Musculoskeletal v0.3
32/33
i.e. as the concentration increases, the % bound decreases (increases %free)
Leads to non-linear effects at higher doses due to this % increase in freedrug
As expected, the effects are linear with respect to the unbound drugthough
Which means it's easier to get to those high doses as well
But the metabolism is also saturable, where increasing the dose means asmaller % is cleared (because only a certain fixed maximum amount can be
cleared)
Overall, just remember the dose-concentration curve relies on theconcentration of the free drug
Concentration-effect relationships
Unbound gives a much better result compared to boundAt least it correlates with S as well, but for some reason it also
correlated with R+S as well
Concentration of the drug at the site is important
Important for action due to correlation between concentration andantipyretic, analgesic and anti-inflammatory action
Correlation between NSAID concentration and GI toxicity as well
In summary:
Disease and chronobiological effects
Increased effects
Easier access of free drug to joints? We're not sureIncreased Vd
Especially diclofenac as it's more suseptible to hepaticclearance (remember: more free, the more the liver canremove)
Also affects renal clearance as well (more unbound= morerenally cleared)
Increased clearance (due to more free drug)
Increased free concentrations of NSAIDSSerum albumin reduced (hypoalbuminaemina)
Evidence of 'trapping' of NSAIDs at the joint, reduced clearance from the joint
Longer effect seen compared to plasma levels
Reduced blood flow in the joint
Rheumatoid arthritis
Increased free concentration (see above again)Plus increased free concentration isn't just important for renal clearance,it's also important for dialysis (same principles)
Hypoalbuminaemina
Increases free concentration
Increased competitors for albumin binding (probably due to accumulation of waste products)
Azapropazone is secreted renally, avoid in renal failure
Renally secreted NSAIDs will have their Clearance decreased, leading to
increased plasma concentrations
Glucouridated NSAIDs tend to build up due to reduced clearance, and the factthat they can be regenerated again within the body (doesn't have to leave,spontaneous hydrolysis)
Renal failure
Musculoskeletal Page 32
7/31/2019 Musculoskeletal v0.3
33/33
Naproxen is one of theseJust try to avoid NSAIDs in renal failure because they will block COX, whichproduces PGE2, which is responsible for vasodilation in renal arteries. If thisdilation is lost, then it could become constricted leading to massive ischemiaand damage to the kidneys
Increased free concentrationAgain hypoalbuminaenemia
First-pass metabolism is lowAbsorption is unaffected
Diclofenac and ibuprofen being examplesClearance for hepatically metabolised NSAIDs is reduced
Hepatic disease
So everything aboveTends to have co-existing morbidities like renal or hepatic failure
Especially the Phase I enzymes (oxidation being important in the
clearance of ibuprofen)
Generally causes decreased clearance
Plus they tend to have reduced liver function
Gives the same results as renal failureGlomerular Filtration Rate (GFR) decreases with age
Reduced VdTotal body water decreases, body fat increases
Elderly patients
Side effects
Increased concentrationInhibits renal lithium excretion
Increased free concentration, leads to increased bleedingCompetes with warfarin for plasma binding
Increased concentrationInhibits phenytoin metabolism
Pharmacokinetic
Antagonistic actions, where ACE inhibitors keep vasodilation, butNSAIDs will cause vasoconstriction in the kidneysMay cause increases in blood pressure or renal failure (unlikely)
Interaction with ACE inhibitors
Somehow increases insulin release to cause hypoglycemiaInteraction with glicazide
Pharmacodynamic